pRK5-HA-GST-4EBP1-Low GC Citations (1)

Originally described in: A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.
Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM Cancer Discov. 2014 May;4(5):554-63. doi: 10.1158/2159-8290.CD-13-0929. Epub 2014 Mar 14. PubMed Journal

---

Articles Citing pRK5-HA-GST-4EBP1-Low GC

Articles
Graded activation of the CLEAR network through mTORC1 suppression on cargo-harboring lysosomes. Hsieh CW, Chen GC, Yang WY. Cell Rep. 2026 Apr 9;45(4):117228. doi: 10.1016/j.celrep.2026.117228. PubMed

If you have published an article using this material, please email us at to have your article added to this page.